Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$3,869,216
+$459,843 QoQ
Shares Held
15,376
-1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.72%
of 13F equity value
Holder Rank
#1,478
of 4,153 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lakeside Advisors, INC. holds $12,885,078 across 8 Drug Manufacturers - General names. ABBV ranks #2 (30.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,640 | $5,495,910 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
15,376 | $3,869,216 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
8,840 | $1,116,845 | |
| 4 | NVO |
Novo Nordisk A S
|
15,950 | $764,643 | |
| 5 | LLY |
ELI LILLY & Co
|
522 | $626,102 | |
| 6 | AMGN |
Amgen Inc
|
1,346 | $487,413 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,809 | $277,094 | |
| 8 | PFE |
Pfizer Inc
|
10,293 | $247,855 |
All Filings in ABBV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,869,216 | 15,376 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $3,409,373 | 15,676 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,581,809 | 15,676 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $3,629,621 | 15,676 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $2,984,027 | 16,076 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $3,514,907 | 16,776 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,998,865 | 16,876 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $3,391,916 | 17,176 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $3,018,923 | 17,601 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $3,277,982 | 18,001 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $2,784,191 | 17,966 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $2,716,022 | 18,221 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $2,508,807 | 18,621 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,983,565 | 18,721 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $3,033,581 | 18,771 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,566,229 | 19,121 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,959,204 | 19,321 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,164,549 | 19,521 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,670,223 | 19,721 | Shares | Sole | 2022-03-08 | |
| No filing history on record for this holder in this stock. | ||||||